Tofacitinib for Focal Myositis in Rheumatoid Arthritis: A Case Report
Author Information
Author(s): Pan Jing, Zheng Haihong, Xu Juan, Pan Shaobiao
Primary Institution: Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University
Hypothesis
Can tofacitinib effectively manage focal myositis in a patient with rheumatoid arthritis?
Conclusion
Tofacitinib may be a valuable treatment option for managing focal myositis in patients with rheumatoid arthritis, especially when corticosteroid tapering is challenging.
Supporting Evidence
- The patient was initially misdiagnosed with infections and did not respond to antibiotics.
- Tofacitinib was introduced after corticosteroid tapering led to symptom recurrence.
- The patient maintained a relapse-free status for over two years after treatment.
Takeaway
This study is about a woman with rheumatoid arthritis who had a rare muscle problem called focal myositis. She got better after taking a medicine called tofacitinib.
Methodology
The patient was treated with tofacitinib after being misdiagnosed and undergoing various treatments, with significant symptom improvement observed.
Potential Biases
Potential bias in diagnosis due to initial misdiagnoses and treatment responses.
Limitations
The case report is based on a single patient, limiting generalizability.
Participant Demographics
A 58-year-old female with a 10-year history of rheumatoid arthritis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website